Biofabrication is a process by which scientists can regrow most types of human tissue using 3D printers. The Queensland University of Technology’s (QUT) biofabrication research is well-advanced in printing 3D custom-made scaffolds using bio-ink infused with the patient’s stem cells to enable the body to grow a new breast after mastectomy. They have recently joined hands with 3 other leaders in the field to provide a detailed and comprehensive Master’s Degree in Bioprinting or BioFabrication.

The four universities offering the two-year, two-degree master’s program are: QUT in Queensland, the University of Wollongong in NSW, the University Medical Center Utrecht in the Netherlands and the University of Würzburg in Germany.

The two year program provides students one Master’s degree in Regenerative medication & Technology from all the universities. The University of Wollongong has created headlines for the utilization of alga and 3D printing to repair broken tissue. Each of the universities, along with their European counterparts, can fulfill the anticipated demand for bioprinting researchers, further as drawing students to the individual countries for the exciting and growing field of 3D written tissues and implants.

Professor Dietmar W. Hutmacher, leader of QUT’s biofabrication analysis, explains the new program can profit Australia and also the students themselves, “This degree could be a very important step in guaranteeing Australia could be a high-value, sophisticated manufacturer within the future. Graduates are going to be at the forefront of a trade which will perpetually be in high demand given the ageing of populations round the world and that cannot be simply replicated by the other country. Each of the four universities has established documentation in key areas of biofabrication, as well as chemical compound chemistry, cell biology and clinical implant

Australian students can study for 9 to 12 months at one in every of the European faculties, whereas European students can do vice versa at the Australian universities. Hutmacher adds, “Graduates of the new Master’s degree can gain a global career and have the power to steer this exciting medical revolution that grows to be notably necessary for our ageing populations.”